Literature DB >> 32587410

Ripretinib for advanced gastrointestinal stromal tumours.

Katrina Ray1.   

Abstract

Entities:  

Year:  2020        PMID： 32587410     DOI： 10.1038/s41575-020-0336-2

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.

Authors:  Jean-Yves Blay; César Serrano; Michael C Heinrich; John Zalcberg; Sebastian Bauer; Hans Gelderblom; Patrick Schöffski; Robin L Jones; Steven Attia; Gina D'Amato; Ping Chi; Peter Reichardt; Julie Meade; Kelvin Shi; Rodrigo Ruiz-Soto; Suzanne George; Margaret von Mehren
Journal:  Lancet Oncol       Date:  2020-06-05       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.